Inogen Inc. (INGN) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Inogen Inc. (INGN:NASDAQ), powered by AI.

Current Price
$6.41
P/E Ratio
-7.5
Market Cap
171M
Sector
Healthcare
What is the Inogen Inc. stock price forecast?

Inogen Inc. is currently trading at $6.41. View real-time AI analysis on Alpha Lenz.

What is Inogen Inc. insider trading activity?

View the latest insider trading data for Inogen Inc. on Alpha Lenz.

What is Inogen Inc.'s P/E ratio?

Inogen Inc.'s P/E ratio is -7.5.

Inogen Inc.

NASDAQ · INGN
$6.41-0.05(-0.77%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Inogen Inc.'s future dividend policy...
Alpha Chat Insight

Inogen Inc. trades at a P/E of -7.5 (undervalued) with modest ROE of -12.4%.

Ask for details

Company Overview

Inogen Inc. is a medical technology company that specializes in innovative respiratory products designed to improve the quality of life for patients with chronic respiratory conditions. Notably, Inogen focuses on developing portable oxygen concentrators, which offer users greater mobility and independence compared to traditional oxygen tanks. These devices are particularly impactful in the healthcare sector, providing respiratory patients with an effective, convenient solution for supplementing oxygen therapy. Inogen's products are utilized by both patients and healthcare providers, addressing the needs of diverse settings, including home care and medical institutions. The company's commitment to research and development underscores its dedication to advancing respiratory care technology. Headquartered in Goleta, California, Inogen collaborates with distributors and resellers globally, enhancing its market reach and significance. In the broader financial market context, Inogen plays a crucial role in the healthcare technology sector, contributing to advancements in patient care and supporting a more dynamic and innovative approach to medical treatment for chronic illnesses. Established in 2001, the company continues to expand its footprint as a leader in portable oxygen solutions.

CEOMr. Kevin R. M. Smith
SectorHealthcare
IndustryMedical Devices
Employees766

Company Statistics

FY 2025

Profile

$170.52MMarket Cap
$348.67MRevenue
0.00Shares Out
766Employees

Margins

44.24%Gross
-2.74%EBITDA
-8.66%Operating
-6.71%Pre-Tax
-6.52%Net

Valuation

-7.50P/E
0.89P/B
0.49EV/Sales
-8.83EV/EBITDA
-7.89P/FCF

Growth (CAGR)

-2.59%Rev 3Yr
2.48%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-7.65%ROA
-12.43%ROE
-10.16%ROIC

Financial Health

$103.73MCash & Cash Equivalents
$2.67MNet Debt
55.35%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Inogen Inc. (ticker: INGN) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 766 employees. Market cap is $171M.

The current price is $6.41 with a P/E ratio of -7.5x and P/B of 0.89x.

ROE is -12.43% and operating margin is -8.66%. Annual revenue is $349M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Inogen Inc. (INGN) Stock Forecast 2026 $6.41 — Price, Financials & Analyst Targets | Alpha Lenz